Morgan Stanley
CGEN icon

Morgan Stanley’s Compugen CGEN Stock Holding History

Morgan Stanley’s Portfolio CGEN Stock Details CGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.24M Buy
1,053,229
+43,528
+4% +$84.5K ﹤0.01% 4692
2025
Q4 		$1.54M Sell
1,009,701
-50,036
-5% -$83.1K ﹤0.01% 4960
2025
Q3 		$1.56M Sell
1,059,737
-254,379
-19% -$378K ﹤0.01% 4926
2025
Q2 		$2.34M Sell
1,314,116
-73,140
-5% -$108K ﹤0.01% 4600
2025
Q1 		$2.03M Buy
1,387,256
+566,911
+69% +$1.11M ﹤0.01% 4593
2024
Q4 		$1.26M Buy
820,345
+64,498
+9% +$105K ﹤0.01% 4971
2024
Q3 		$1.37M Buy
755,847
+1,912
+0.3% +$3.49K ﹤0.01% 4860
2024
Q2 		$1.27M Sell
753,935
-7,067
-0.9% -$14.7K ﹤0.01% 4830
2024
Q1 		$1.96M Sell
761,002
-782,336
-51% -$1.82M ﹤0.01% 4590
2023
Q4 		$3.06M Buy
1,543,338
+759,991
+97% +$664K ﹤0.01% 4703
2023
Q3 		$729K Buy
783,347
+4,971
+0.6% +$5.47K ﹤0.01% 4982
2023
Q2 		$887K Sell
778,376
-13,821
-2% -$12K ﹤0.01% 4900
2023
Q1 		$556K Buy
792,197
+51,791
+7% +$42.6K ﹤0.01% 5193
2022
Q4 		$530K Sell
740,406
-329,663
-31% -$288K ﹤0.01% 5216
2022
Q3 		$704K Sell
1,070,069
-50,664
-5% -$71.5K ﹤0.01% 5090
2022
Q2 		$2.08M Sell
1,120,733
-62,998
-5% -$136K ﹤0.01% 4511
2022
Q1 		$3.81M Sell
1,183,731
-98,844
-8% -$334K ﹤0.01% 3971
2021
Q4 		$5.52M Sell
1,282,575
-340,723
-21% -$1.84M ﹤0.01% 3619
2021
Q3 		$9.69M Sell
1,623,298
-166,669
-9% -$1.12M ﹤0.01% 2929
2021
Q2 		$14.8M Buy
1,789,967
+157,025
+10% +$1.27M ﹤0.01% 2517
2021
Q1 		$14M Buy
1,632,942
+446,332
+38% +$4.95M ﹤0.01% 2295
2020
Q4 		$14.4M Sell
1,186,610
-138,872
-10% -$1.92M ﹤0.01% 2138
2020
Q3 		$21.5M Buy
1,325,482
+291,950
+28% +$4.78M ﹤0.01% 1430
2020
Q2 		$15.5M Buy
1,033,532
+163,801
+19% +$2.21M ﹤0.01% 1600
2020
Q1 		$6.31M Sell
869,731
-83,312
-9% -$654K ﹤0.01% 2223
2019
Q4 		$5.68M Buy
953,043
+11,530
+1% +$59.3K ﹤0.01% 3059
2019
Q3 		$3.98M Sell
941,513
-93,662
-9% -$350K ﹤0.01% 3116
2019
Q2 		$3.98M Buy
1,035,175
+21,368
+2% +$75.6K ﹤0.01% 3153
2019
Q1 		$4.2M Buy
1,013,807
+69,714
+7% +$239K ﹤0.01% 2872
2018
Q4 		$2.05M Sell
944,093
-54,080
-5% -$171K ﹤0.01% 3744
2018
Q3 		$3.84M Buy
998,173
+27,240
+3% +$95.3K ﹤0.01% 3460
2018
Q2 		$3.2M Buy
970,933
+5,154
+0.5% +$19.4K ﹤0.01% 3632
2018
Q1 		$4.3M Buy
965,779
+10,887
+1% +$36.7K ﹤0.01% 3185
2017
Q4 		$2.39M Buy
954,892
+69,327
+8% +$206K ﹤0.01% 3876
2017
Q3 		$3.37M Buy
885,565
+28,734
+3% +$99.7K ﹤0.01% 3376
2017
Q2 		$3.26M Buy
856,831
+43,631
+5% +$181K ﹤0.01% 3330
2017
Q1 		$3.5M Buy
813,200
+69,754
+9% +$322K ﹤0.01% 3257
2016
Q4 		$3.79M Buy
743,446
+29,736
+4% +$178K ﹤0.01% 3290
2016
Q3 		$4.5M Buy
713,710
+13,630
+2% +$92.3K ﹤0.01% 2760
2016
Q2 		$4.54M Sell
700,080
-1,889
-0.3% -$12.6K ﹤0.01% 2707
2016
Q1 		$3.92M Buy
701,969
+1,850
+0.3% +$9.66K ﹤0.01% 2753
2015
Q4 		$4.47M Buy
700,119
+22,092
+3% +$145K ﹤0.01% 2769
2015
Q3 		$3.5M Buy
678,027
+45,135
+7% +$263K ﹤0.01% 2967
2015
Q2 		$4.39M Buy
632,892
+24,978
+4% +$175K ﹤0.01% 2900
2015
Q1 		$4.29M Buy
607,914
+8,103
+1% +$66.3K ﹤0.01% 2892
2014
Q4 		$5M Sell
599,811
-9,307
-2% -$71.6K ﹤0.01% 2737
2014
Q3 		$5.22M Buy
609,118
+3,767
+0.6% +$33.4K ﹤0.01% 2601
2014
Q2 		$5.44M Buy
605,351
+14,827
+3% +$133K ﹤0.01% 2600
2014
Q1 		$6.21M Buy
590,524
+54,309
+10% +$598K ﹤0.01% 2367
2013
Q4 		$4.8M Sell
536,215
-4,831
-0.9% -$47.2K ﹤0.01% 2599
2013
Q3 		$5.55M Buy
541,046
+2,626
+0.5% +$20.4K ﹤0.01% 2323
2013
Q2 		$2.92M Buy
+538,420
New +$3.04M ﹤0.01% 2829

Other funds holding CGEN

SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
YLHM
Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley's CGEN Position: Q1 2026 in Review

Morgan Stanley increased its Compugen (CGEN) stake by 4.3% in Q1 2026, buying an estimated $84.5K and bringing the position to 1,053,229 shares worth $2.24M. The position accounts for ﹤0.01% of the portfolio, ranked #4692.

Morgan Stanley first reported a position in CGEN in Q2 2013 and has held it in 52 quarters since. The position peaked at $21.5M in Q3 2020. 78 funds tracked by Wall St. Rank hold CGEN as of Q1 2026.

  • Morgan Stanley held 1,053,229 shares of Compugen worth $2.24M as of Q1 2026.
  • Morgan Stanley bought 43,528 Compugen shares in Q1 2026, an estimated $84.5K.
  • Compugen made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #4692 holding.
  • Morgan Stanley first reported a position in Compugen in Q2 2013 and has held it in 52 quarters since.
  • Morgan Stanley's Compugen position peaked at $21.5M in Q3 2020.
  • 78 funds tracked by Wall St. Rank held Compugen as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.